Furthermore, innate immune responses to gut microbiota through TLR4 signaling have been implicated in gastrointestinal malignancies (12), with experimental evidence showing that blocking TLR4-MyD88 signaling suppresses inflammation-associated tumor development (11, 13). Here, MYD88 is linked to neoplasm.